Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Leber's hereditary optic neuropathy associated with multiple sclerosis: Harding's syndrome.
Laquinimod suppress antigen presentation in relapsing-remitting multiple sclerosis: in-vitro high-throughput gene expression study.
Neuronal NF-κB ablation does not influence neuro-axonal degeneration in experimental autoimmune demyelination.
MP2RAGE Multiple Sclerosis Magnetic Resonance Imaging at 3 T.
Detecting cortical lesions in multiple sclerosis at 7 T using white matter signal attenuation.
Don't stress about it!: Is stress management a disease-modifying therapy for multiple sclerosis?
The cost burden of multiple sclerosis in the United States: a systematic review of the literature.
Progressive Multifocal Leukoencephalopathy
The NOX1/4 Inhibitor GKT136901 as Selective and Direct Scavenger of Peroxynitrite.
Differential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon.
Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved.
Norovirus-related chronic diarrhea in a patient treated with alemtuzumab for chronic lymphocytic leukemia.
Amiloride Clinical Trial In Optic Neuritis (ACTION)
Safety Study of GNbAC1 in Multiple Sclerosis Patients
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis.
Identifying autoantigens in demyelinating diseases: valuable clues to diagnosis and treatment?
Vinpocetine inhibits oligodendroglial precursor cell differentiation.
Sexual dysfunction ın multiple sclerosis: Gender differences.
[The influence of locomotor treatment using robotic body-weight-supported treadmill training on rehabilitation outcome of patients suffering from neurological disorders].
Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter, Phase IIIb REFORMS study.
A comparative study of experimental mouse models of central nervous system demyelination.
Study Suggests Targeting B Cells May Help with MS
Mapi Pharma Receives Additional Claims for Its U.S. Patent for Glatiramer Acetate Depot for the Treatment of Multiple Sclerosis
Mechanism of action, pharmacokinetics, adverse effects, and therapeutic uses of amiloride hydrochloride, a new potassium-sparing diuretic.
Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS) (ALLEGRO)

Pages